Try Alerts Free   |   Login
Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

CRBU Price Correlated With Financials For Caribou Biosciences

Free historical financial statements for Caribou Biosciences Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 4 quarters since 2021. Compare with CRBU stock chart to see long term trends.

CRBU Stock Compared to Quarterly

CRBU Income Statement

Revenue, Net:2664000
Revenue Per Share:0.0439
Selling, General & Admin Expense:9593000
Research & Development Expense:13924000
Total Operating Expenses:23517000
Operating Income:-20853000
Income Taxes:0
Net Income:-19088000
Earnings Per Share, Basic:-0.32
Shares Outstanding, Basic Avg:60705391

CRBU Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:308000
Change in Accounts Receiveable:-779000
Net Cash from Operations:-21673000
Net Cash from Operations Per Share:-0.357
Net Cash from Financing Activities:990000
Property, Plant & Equipment Purchases:723000
Net Cash from Investing Activities:-72107000
Net Change in Cash & Equivalents:-92790000

CRBU Balance Sheet

Cash and Cash Equivalents:390800000
Short-Term Investments:206101000
Accounts Receivable, Net:374000
Total Current Assets:368010000
Property, Plant & Equipment, Net:6016000
Total Assets:445997000
Accounts Payable:1814000
Total Short-Term Liabilities:26667000
Total Liabilities:74200000

Data imported from Caribou Biosciences Inc. SEC filings. Check original filings before making any investment decision.